Antares Pharma, Inc.

Form 483

Minnetonka, Minnesota, United StatesFEI 2182861Issued January 21, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2182861.

Observations2

Issue DateJanuary 21, 2016

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: Antares Pharma, Inc.
Location: Minnetonka, Minnesota, United States
FEI Number: 2182861
Product Type: Devices
Issue Date: January 21, 2016
Country: United States

Inspection History, 2009 to 2025

NAI4

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Antares Pharma, Inc. FDA Form 483, Minnetonka, Minnesota, January 21, 2016